| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11994-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81270SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35032-10ug | |||
| Carrier-Free | NBP2-35032-1mg | |||
| Carrier-Free | NBP2-35032-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35029-10ug | |||
| Carrier-Free | NBP2-35029-1mg | |||
| Carrier-Free | NBP2-35029-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34911-1mg | |||
| Carrier-Free | NBP2-34911-100ug | |||
| Carrier-Free | NBP2-34911-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75194-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-09026-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26690-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26689-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26687-50ul | |||
![Western Blot: CCR4 Antibody (KW-0761 (Mogamulizumab)) - Chimeric [NBP2-81270] - Western Blot using CCR4 Antibody (KW-0761 (Mogamulizumab)) [NBP2-81270]. Human brain cerebellum (A) and human heart (B) lysates (35ug protein in RIPA buffer) were resolved on a 10% SDS PAGE gel and blots probed with the chimeric rabbit IgG version of KW-0761 [NBP2-81270] at 2 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence. The expected running size for CCR4 is 37.7kDa.](http://images.novusbio.com/fullsize/CCR4-Antibody-KW-0761-Mogamulizumab-Chimeric-Western-Blot-NBP2-81270-img0001.jpg "Western Blot: CCR4 Antibody (KW-0761 (Mogamulizumab)) - Chimeric [NBP2-81270] - Western Blot using CCR4 Antibody (KW-0761 (Mogamulizumab)) [NBP2-81270]. Human brain cerebellum (A) and human heart (B) lysates (35ug protein in RIPA buffer) were resolved on a 10% SDS PAGE gel and blots probed with the chimeric rabbit IgG version of KW-0761 [NBP2-81270] at 2 ug/ml before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence. The expected running size for CCR4 is 37.7kDa.")
![SDS-Page: Human IL-16 130 a.a Protein [NBP2-35032]](http://images.novusbio.com/fullsize/Human-IL-16-130-a.a-Protein-SDS-Page-NBP2-35032-img0001.jpg "SDS-Page: Human IL-16 130 a.a Protein [NBP2-35032]")
![SDS-Page: Human IL-16 121 a.a Protein [NBP2-35029]](http://images.novusbio.com/fullsize/Human-IL-16-121-a.a-Protein-SDS-Page-NBP2-35029-img0001.jpg "SDS-Page: Human IL-16 121 a.a Protein [NBP2-35029]")
![SDS-Page: Human CXCL10/IP-10/CRG-2 Protein [NBP2-34911]](http://images.novusbio.com/fullsize/Human-CXCL10-IP-10-CRG-2-Protein-SDS-Page-NBP2-34911-img0001.jpg "SDS-Page: Human CXCL10/IP-10/CRG-2 Protein [NBP2-34911]")
![ELISA: CCR4 Antibody (12F5) [NBP3-26690] - The Binding Activity of CCR4 with CCR4 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized CCR4 at 10 ug/mL can bind CCR4 Antibody, the EC50 is 362.3-630.8 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26690_human-ccr4-mab-12f5-262202412272326.jpg "ELISA: CCR4 Antibody (12F5) [NBP3-26690] - The Binding Activity of CCR4 with CCR4 Antibody. Activity: Measured by its binding ability in a functional ELISA. Immobilized CCR4 at 10 ug/mL can bind CCR4 Antibody, the EC50 is 362.3-630.8 ng/mL.")
![Flow Cytometry: CCR4 Antibody (12F5) [NBP3-26690] - Untransfected HEK293 cells (green line) and transfected Human CCR4 HEK293 stable cells (red line) were stained with anti-CCR4 antibody(2ul/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26690_human-ccr4-mab-12f5-282202414312746.jpg)
![Flow Cytometry: CCR8 Antibody (10A9) [NBP3-26689] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 recombinant antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26689_human-ccr8-mab-10a9-282202414183648.jpg "Flow Cytometry: CCR8 Antibody (10A9) [NBP3-26689] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 recombinant antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.")
![Flow Cytometry: CCR8 Antibody (10A9) [NBP3-26689] - Untransfected HEK293T cells (green line) and transfected Human CCR8 HEK293T stable cells (red line) were stained with anti-CCR8 recombinant antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26689_human-ccr8-mab-10a9-282202414312737.jpg)
![Flow Cytometry: CCR8 Antibody (6B12) [NBP3-26687] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.](http://images.novusbio.com/fullsize/nbp3-26687_human-ccr8-mab-6b12-282202414312712.jpg "Flow Cytometry: CCR8 Antibody (6B12) [NBP3-26687] - Untransfected CHO-K1 cells (green line) and transfected Human CCR8 CHO-K1 stable cells (red line) were stained with anti-CCR8 antibody (2ug/1*10^6 cells), washed and then followed by FITC-conjugated anti-Human IgG Fc antibody and analyzed with flow cytometry.")
![ELISA: Human CCR8 mAb (6B12) [NBP3-26687] - The Binding Activity of CCR8 with Anti-CCR8 recombinant antibody.Activity: Measured by its binding ability in a functional ELISA. Immobilized Human CCR8 at 5 μg/mL can bind Anti-CCR8 recombinant antibody, the EC50 is 11.20-15.63 ng/mL.](http://images.novusbio.com/fullsize/nbp3-26687_human-ccr8-mab-6b12-elisa-1312025165326..jpg)